Who
Ryan M. Confer
President, CEO and CFO
Company insider
Files Form 4 as: President, CEO and CFO, Genprex.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 23 May 2018
- Last trade
- 27 Feb 2026
- Last filed
- 27 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Feb 2026filed 27 Feb 2026 | GNPX GenprexBiotechnology | SEC FORM 4 Code F | $19K9,330 at $2.00 | filing |
| 27 Feb 2026filed 27 Feb 2026 | GNPX GenprexBiotechnology | SEC FORM 4 Code F | $19K9,330 at $2.00 | filing |
| 22 Dec 2025filed 23 Dec 2025 | GNPX GenprexBiotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 30 Jun 2025filed 1 Jul 2025 | GNPX GenprexBiotechnology | SEC FORM 4 Code F | $1,3285,775 at $0.23 | filing |
| 18 Feb 2025filed 19 Feb 2025 | GNPX GenprexBiotechnology | SEC FORM 4 Code F | $162395 at $0.41 | filing |
| 5 Dec 2024filed 6 Dec 2024 | GNPX GenprexBiotechnology | SEC FORM 4 Code A | —29,375 at $0.00 | filing |
| 18 Feb 2024filed 21 Feb 2024 | GNPX GenprexBiotechnology | SEC FORM 4 Code F | $4,9541,126 at $4.40 | filing |
| 18 Feb 2023filed 22 Feb 2023 | GNPX GenprexBiotechnology | SEC FORM 4 Code A | —245,000 at $0.00 | filing |
| 28 Jul 2022filed 1 Aug 2022 | GNPX Genprexoption or derivative · Biotechnology | SEC FORM 4 Code M | —116,973 at $0.00 | filing |
| 28 Jul 2022filed 1 Aug 2022 | GNPX GenprexBiotechnology | SEC FORM 4 Code M | $2,339116,973 at $0.02 | filing |
| 4 Feb 2022filed 8 Feb 2022 | GNPX Genprexoption or derivative · Biotechnology | SEC FORM 4 Code A | —341,750 at $0.00 | filing |
| 19 Mar 2021filed 23 Mar 2021 | GNPX Genprexoption or derivative · Biotechnology | SEC FORM 4 Code A | —235,000 at $0.00 | filing |
| 21 Aug 2020filed 25 Aug 2020 | GNPX Genprexoption or derivative · Biotechnology | SEC FORM 4 Code A | —270,000 at $0.00 | filing |
| 25 Jan 2019filed 29 Jan 2019 | GNPX Genprexoption or derivative · Biotechnology | SEC FORM 4 Code A | —230,769 at $0.00 | filing |
| 23 May 2018filed 25 May 2018 | GNPX Genprexoption or derivative · Biotechnology | SEC FORM 4 Code A | —327,236 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.